Fairtility Uses CHLOE EQ to Expand into European Market, as Five Countries Adopt Revolutionary AI Technology in IVF Clinics

AI innovator, Fairtility, has expanded its footprint across Europe a year after receiving CE MDR clearance for CHLOE EQ. The company has established a presence in clinics in five countries, including the UK, Spain, Turkey, Greece, and Norway. CHLOE EQ is an AI tool that provides both embryo selection capabilities and a transparent IVF experience for patients. It has been implemented in over ten clinics thus far, and has enabled clinics to reduce time spent on manual embryo annotation by an average of 33% per cycle, resulting in a 30-50% increase in IVF cycle capacity. Fairtility is supporting clinics in their digital transformation for the IVF journey. CHLOE EQ integrates with leading IVF EMR providers, enabling data to flow freely from lab-to-fertility specialist-to-patient, paving the path for more open communication on treatment plans and progress.